Form 8-K - Current report:
SEC Accession No. 0000930413-21-001095
Filing Date
2021-05-17
Accepted
2021-05-17 07:36:40
Documents
15
Period of Report
2021-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c101741_8k-ixbrl.htm   iXBRL 8-K 24115
2 c101741_ex99-1.htm EX-99.1 11924
3 GRAPHIC image_001.jpg GRAPHIC 5098
  Complete submission text file 0000930413-21-001095.txt   194509

Data Files

Seq Description Document Type Size
4 nmtr-20210517.xsd EX-101.SCH 3261
5 nmtr-20210517_def.xml EX-101.DEF 11374
6 nmtr-20210517_lab.xml EX-101.LAB 23329
7 nmtr-20210517_pre.xml EX-101.PRE 11818
8 EXTRACTED XBRL INSTANCE DOCUMENT c101741_8k-ixbrl_htm.xml XML 2631
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

EIN.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 21927572
SIC: 2834 Pharmaceutical Preparations